Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Role of interdisciplinary strategies in liver metastases

Role of interdisciplinary strategies in liver metastases Metastases of the liver are a common event in malignancies particularly of the gastrointestinal tract and a leading cause of cancer-related death. Until a few years ago, treatment for these patients was given based on palliative strategies. Today there is considerable hope for cure owing to recent developments of both surgical techniques of liver resection and chemotherapy. Liver surgery has become a safe and widespread procedure with postoperative morbidity rate of less than 40% and mortality rate of less than 5%. At the time of diagnosis, only a small amount of patients with liver metastases are resectable. Therefore, efforts have been made to increase the proportion of resectable patients, who may be considered for potential curative resection. Besides extended surgical techniques, possibly in combination with ablative procedures, preoperative chemo- and targeted therapy have become the leading means to gain resectability. Particularly in patients with metastasis of colorectal cancer (CRC) significant advances have been made over the last decade and recently the use of neoadjuvant treatment to downsize disease followed by liver resection was demonstrated to improve patients' survival. Besides curative surgery, tumour de-bulking was shown to be of abundant benefit for patients suffering from neuroendocrine tumours (NET) with liver metastasis owing to relieve or control symptoms. Liver resection is nowadays even extended for non-CRC and non-NET metastases, depending on the clinical course of the primary disease. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png memo - Magazine of European Medical Oncology Springer Journals

Role of interdisciplinary strategies in liver metastases

Download PDF
4 pages

Loading next page...
 
/lp/springer-journals/role-of-interdisciplinary-strategies-in-liver-metastases-c0sDpsKfh7
Publisher
Springer Journals
Copyright
Copyright © 2009 by Springer-Verlag
Subject
Medicine & Public Health; Oncology; Medicine/Public Health, general
ISSN
1865-5041
eISSN
1865-5076
DOI
10.1007/s12254-009-0100-3
Publisher site
See Article on Publisher Site

Abstract

Metastases of the liver are a common event in malignancies particularly of the gastrointestinal tract and a leading cause of cancer-related death. Until a few years ago, treatment for these patients was given based on palliative strategies. Today there is considerable hope for cure owing to recent developments of both surgical techniques of liver resection and chemotherapy. Liver surgery has become a safe and widespread procedure with postoperative morbidity rate of less than 40% and mortality rate of less than 5%. At the time of diagnosis, only a small amount of patients with liver metastases are resectable. Therefore, efforts have been made to increase the proportion of resectable patients, who may be considered for potential curative resection. Besides extended surgical techniques, possibly in combination with ablative procedures, preoperative chemo- and targeted therapy have become the leading means to gain resectability. Particularly in patients with metastasis of colorectal cancer (CRC) significant advances have been made over the last decade and recently the use of neoadjuvant treatment to downsize disease followed by liver resection was demonstrated to improve patients' survival. Besides curative surgery, tumour de-bulking was shown to be of abundant benefit for patients suffering from neuroendocrine tumours (NET) with liver metastasis owing to relieve or control symptoms. Liver resection is nowadays even extended for non-CRC and non-NET metastases, depending on the clinical course of the primary disease.

Journal

memo - Magazine of European Medical Oncology – Springer Journals

Published: Jan 1, 2009

References

  • The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment
    Wagner, JS; Adson, MA; Van Heerden, JA
  • Consensus on the medical treatment of colon cancer
    Kornek, G; Scheithauer, W; Anghel, R
  • Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect
    Elias, D; Liberale, G; Vernerey, D
  • Standard surgical resection of colorectal liver metastases
    Bechstein, WO; Golling, M
  • Actual 10-year survival after resection of colorectal liver metastases defines cure
    Tomlinson, JS; Jarnagin, WR; DeMatteo, RP
  • Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases
    Fong, Y; Fortner, J; Sun, RL
  • Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group
    Nordlinger, B; Van Cutsem, E; Rougier, P
  • Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
    Nordlinger, B; Sorbye, H; Glimelius, B
  • Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial
    Portier, G; Elias, D; Bouche, O
  • Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases
    Adam, R; Avisar, E; Ariche, A
  • Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery
    Giacchetti, S; Itzhaki, M; Gruia, G
  • Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma
    Rivoire, M; De Cian, F; Meeus, P
  • Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid
    Wein, A; Riedel, C; Köckerling, F
  • Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer
    Gruenberger, B; Tamandl, D; Schueller, J
  • Approaching personalized cancer medicine
    Gastl, G
  • Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases
    Aloia, T; Sebagh, M; Plasse, M
  • Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
    Vauthey, JN; Pawlik, TM; Ribero, D
  • Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?
    Adam, R; Pascal, G; Castaing, D
  • Karnofsky memorial lecture: an odyssey in the land of small tumors
    Moertel, CG
  • Prognostic factors in patients with endocrine tumours of the duodenopancreatic area
    Madeira, I; Terris, B; Voss, M
  • Neuroendocrine Hepatic Metastases. Does aggressive management improve survival?
    Touzios, JG; Kiely, JM; Pitt, SC
  • Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival
    Sarmiento, JM; Heywood, G; Rubin, J
  • Results of liver transplantation in the treatment of metastatic neuroendocrine tumors
    Le Treut, YP; Delpero, JR; Dousset, B
  • Hepatectomy for metastatic noncolorectal gastrointestinal, breast and testicular tumours
    Metcalfe, MS; Mullin, EJ; Maddern, GJ
  • Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas
    Nunobe, S; Sano, T; Shimada, K
  • An attempt to clarify indications for hepatectomy for liver metastases from breast cancer
    Elias, D; Maisonnette, F; Druet-Cabanac, M
  • Hepatic resection of metastatic testicular carcinoma: a further update
    Hahn, TL; Jacobson, L; Einhorn, LH
  • Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma
    Weitz, J; Blumgart, LH; Fong, Y